title: The Immune System and AMD.
abstract: Age related macular degeneration (AMD) is a complex, multifactorial disease that has yet to be completely understood. Significant efforts in the basic and clinical sciences have unveiled numerous areas which appear to be critical in the pathogenesis of this disease. The alternative complement pathway, immune cell activation, and autoimmunity are all emerging as important themes to the suspected immunologic origins of this disease. Advancement toward a complete understanding of these processes is important in development of new techniques for disease monitoring and treatment.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Frederick
authors.forename: Mark E
authors.initials: ME
authors.lastname: Kleinman
keywords: AMD; anti-retinal autoantibodies; chemokine receptors; choroidal neovascularization; complement pathways; drusen; immunology; macrophage; toll-like receptors
references.citation: Science. 2005 Apr 15;308(5720):419-21
references.pmid: 15761120
references.citation: Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3578-85
references.pmid: 12882810
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2328-33
references.pmid: 16452172
references.citation: J Biol Chem. 2006 Aug 25;281(34):24713-20
references.pmid: 16787919
references.citation: J Clin Invest. 2007 Nov;117(11):3421-6
references.pmid: 17975672
references.citation: J Clin Invest. 2013 May;123(5):2218-30
references.pmid: 23619360
references.citation: Nat Genet. 2000 Jun;25(2):187-91
references.pmid: 10835634
references.citation: Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5614-8
references.pmid: 19628747
references.citation: Am J Ophthalmol. 2004 Sep;138(3):323-8
references.pmid: 15364212
references.citation: Hum Mol Genet. 2005 Jun 1;14(11):1449-55
references.pmid: 15829498
references.citation: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
references.pmid: 15870199
references.citation: Bioorg Med Chem. 2008 Jan 1;16(1):49-55
references.pmid: 17521913
references.citation: Science. 2005 Apr 15;308(5720):385-9
references.pmid: 15761122
references.citation: Clin Sci (Lond). 2003 Jan;104(1):27-38
references.pmid: 12519085
references.citation: Invest Ophthalmol Vis Sci. 2013 Nov 13;54(12):7439-49
references.pmid: 24135751
references.citation: Am J Pathol. 2012 Jan;180(1):209-20
references.pmid: 22085974
references.citation: Acta Ophthalmol. 2012 Feb;90(1):e21-4
references.pmid: 21883989
references.citation: Nature. 2008 Apr 3;452(7187):591-7
references.pmid: 18368052
references.citation: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1652-9
references.pmid: 18385087
references.citation: N Engl J Med. 2008 Oct 2;359(14):1456-63
references.pmid: 18753640
references.citation: Immunol Rev. 2001 Apr;180:35-48
references.pmid: 11414361
references.citation: Nat Med. 2003 Nov;9(11):1390-7
references.pmid: 14566334
references.citation: J Clin Invest. 2007 Oct;117(10):2920-8
references.pmid: 17909628
references.citation: N Engl J Med. 2007 Aug 9;357(6):553-61
references.pmid: 17634448
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1080-90
references.pmid: 15909160
references.citation: J Leukoc Biol. 2003 Jul;74(1):25-32
references.pmid: 12832439
references.citation: J Biol Chem. 2003 Oct 24;278(43):42027-35
references.pmid: 12923198
references.citation: PLoS One. 2013 Aug 20;8(8):e71808
references.pmid: 23977149
references.citation: Exp Eye Res. 2001 Dec;73(6):887-96
references.pmid: 11846519
references.citation: Exp Eye Res. 2004 Feb;78(2):243-56
references.pmid: 14729357
references.citation: Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4007-11
references.pmid: 17724180
references.citation: Nat Med. 2008 Feb;14(2):194-8
references.pmid: 18223656
references.citation: Invest Ophthalmol Vis Sci. 2008 Jan;49(1):364-71
references.pmid: 18172114
references.citation: Nature. 2009 Jul 9;460(7252):225-30
references.pmid: 19525930
references.citation: Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3827-36
references.pmid: 17652758
references.citation: Nat Genet. 2006 Apr;38(4):458-62
references.pmid: 16518403
references.citation: Science. 2005 Apr 15;308(5720):421-4
references.pmid: 15761121
references.citation: Ann Med. 2006;38(7):450-71
references.pmid: 17101537
references.citation: Am J Ophthalmol. 2002 Sep;134(3):411-31
references.pmid: 12208254
references.citation: Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3729-35
references.pmid: 16936080
references.citation: Prog Retin Eye Res. 2001 May;20(3):385-414
references.pmid: 11286898
references.citation: Br J Ophthalmol. 2004 Sep;88(9):1217-22
references.pmid: 15317719
references.citation: Graefes Arch Clin Exp Ophthalmol. 1990;228(3):270-4
references.pmid: 2193850
references.citation: FASEB J. 2000 May;14(7):835-46
references.pmid: 10783137
references.citation: Synapse. 2013 Aug;67(8):515-31
references.pmid: 23592324
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 28;52(3):1748-54
references.pmid: 21169531
references.citation: Arch Ophthalmol. 2005 Jul;123(7):914-21
references.pmid: 16009831
references.citation: J Neuroimmunol. 2004 Aug;153(1-2):7-15
references.pmid: 15265658
references.citation: Exp Eye Res. 2006 Oct;83(4):834-40
references.pmid: 16764856
references.citation: Biotechniques. 2010 Apr;48(4):303-11
references.pmid: 20569207
references.citation: FASEB J. 2004 Aug;18(11):1297-9
references.pmid: 15208270
references.citation: PLoS Med. 2006 Aug;3(8):e310
references.pmid: 16903779